5 stocks to buy with £20k in a Stocks and Shares ISA

Rupert Hargreaves looks at five stocks he’d buy today for his Stocks and Shares ISA with £20,000 and a long-term outlook.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

Using a Stocks and Shares ISA is one of the best ways to invest in the market. Any income or capital gains earned on assets held within one of these wrappers doesn’t attract any further tax. Investors don’t even need to declare the income on their tax returns.

I try to make the most of my £20k ISA allowance every year as soon as possible. Here are five stocks I’d buy with my latest allowance today.

Stocks and Shares ISA

Thanks to the tax benefits of an ISA, I think they’re the perfect wrappers in which to own income investments.

I’d buy FTSE 100 healthcare stocks Hikma and GlaxoSmithKline with a portion of my £20,000 investment on this theme. 

Hikma manufactures a range of generic, low-cost medications. Meanwhile, Glaxo is more of a healthcare conglomerate, with treatments spanning from vaccines to oncology and an extensive consumer healthcare portfolio. This mixture provides healthy cash flows to support the firm’s large dividend yield of 5.6%. 

Hikma is more of a dividend growth investment. The stock offers a dividend yield of 1.5%, at the time of writing. Over the past five years, as the company’s earnings have expanded, its per-share dividend has grown at a compound annual rate of nearly 10%. As such, over the long term, I think this could be a fantastic income investment. 

Of course, these assets aren’t risk-free. Dividends are paid out of profits, and if the income at Glaxo or Hikma falls, the payouts could be slashed. Any number of factors could lead to this outcome. A sudden unforeseen economic downturn, legal battle, or higher than expected costs could significantly reduce earnings power. 

Despite these risks, I’d buy Glaxo and Hikma for my Stocks and Shares ISA portfolio today. 

Steady income 

Two other income plays I’d buy are Assura and Airtel Africa. Assura owns medical facilities in the UK, which it leases to healthcare providers. Airtel owns mobile phone towers across Africa.

The stocks offer dividend yields of 3.7% and 4.9% respectively. These payouts aren’t guaranteed. Both companies also use a lot of debt to fund their operations, which could limit their ability to grow the distributions in the long run. 

Still, I’d buy the equities for my Stocks and Shares ISA due to their cash flows from stable infrastructure assets. 

Growth investment 

The final company I’d buy for my £20,000 portfolio is a growth investment. Spirent Communications develops technology for the communications industry, in particular equipment used in 5G networks.

The 5G global services market is expected to grow at a compound annual growth rate of 46.2% from 2021 to 2028. I think if Spirent can grab just a tiny share of this market, it could be an excellent growth investment. 

The main challenge the business faces is standing out in such a competitive market. The market may also not live up to growth expectations. This could mean Spirent’s long-term growth is lower than expected. 


Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has recommended GlaxoSmithKline and Hikma Pharmaceuticals. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

Up 350% in 3 years but my favourite FTSE growth share is still on a low P/E of just 10!

Harvey Jones can't tear his eyes away from this former penny stock turned growth share superpower. But can it carry…

Read more »

Santa Clara offices of NVIDIA
Investing Articles

Up 83% in months, could Micron stock be the next Nvidia?

Chipmaker Micron Technology's stock price has surged by over 80% in just a few months. Could this be a possible…

Read more »

Tesla car at super charger station
US Stock

£1k invested in Tesla stock at the start of the year is currently worth…

Jon Smith reveals the performance of Tesla stock in 2025 and explains why he doesn't believe the move lower is…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

What sort of return could someone get by investing £20,000 in UK dividend shares?

Should UK savers consider dividend shares over cash? Stephen Wright thinks those looking for long-term passive income would be wise…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

Around a 15-year high, is Barclays’ share price still too cheap to ignore?

Barclays’ share price is at a level not seen since 2010, but price and value aren't the same thing, so…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

47% below fair value and with an 18% earnings growth forecast, should investors consider this FTSE retail institution now?

This FTSE 100 British retail institution lost its way for a while but has bounced back in recent years, and…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Lloyds share price: up 40% this year, is it time to take profits?

The booming Lloyds share price is up nearly 40% in 2025, outperforming its UK banking peers. Our writer asks whether…

Read more »

pensive bearded business man sitting on chair looking out of the window
Investing Articles

If the stock market crashes tomorrow, here’s what I’ll do with my portfolio

A stock market crash can feel terrifying. Here’s why staying calm matters – and how this recovering FTSE 100 company…

Read more »